INTRODUCTION
============

Simultaneous processes of protein synthesis and degradation dictate the dynamics of the cellular proteome in eukaryotes \[[@B1]\]. Polyubiquitin (polyUb) modifications drive the destruction of a majority of cellular proteins by targeting them either to the lysosome or to a 2.5 MDa multi-catalytic protease, the 26S proteasome \[[@B2]--[@B4]\]. Structurally, the proteasome consists of a cylindrical proteolytic 20S core particle (CP) capped by a 19S regulatory particle (RP) at either ends \[[@B5],[@B6]\]. By synchronizing polyUb recognition, deubiquitination, substrate unfolding and translocation, these 19S RP caps control proteolytic efficiency \[[@B7]--[@B15]\]. About 20 different subunits with distinguished structural motifs and dedicated functions make up the 19S RP \[[@B5],[@B16]--[@B18]\]. Covering the entry port into the 20S CP, the base contains a ring of six AAA--ATPase subunits (Rpt1, Regulatory particle triple-A ATPase 1--Rpt6) and five additional subunits involved in anchoring or processing polyUb or ubiquitin (Ub)-like domains \[Rpn1, Rpn2, Rpn10, Rpn13 and the transiently associated deubiquitinase (DUB) Ubp6--USP14, ubiquitin-specific processing 14\] \[[@B3],[@B19]\]. Nine subunits make up the lid, two of which Rpn8 (Regulatory particle non-ATPase 8) and Rpn11, belong to the Mpr1/Pad1 N-terminal (MPN)--JAB1/MPN/Mov34 Metalloprotease (JAMM) metalloprotease-related family \[[@B20]\], although only Rpn11 is a functional DUB \[[@B21],[@B22]\]. CryoEM analysis of proteasome holoenzymes benefited from crystal structures of the MPN domains of Rpn11 and Rpn8, to localize them at the centre of the 19S RP in close contact to the RPT ATPases directly above the central pore \[[@B21],[@B23]--[@B27]\]. DUB activity of Rpn11 is greatly enhanced when complexed into 26S proteasome holoenzymes \[[@B10],[@B13],[@B20],[@B28],[@B29]\]. The remaining lid subunits (Rpn3, Rpn5, Rpn6, Rpn7, Rpn9, Rpn12) form a horseshoe arrangement through their C-terminal PCI (porteasome, COP9 signalosome, eukaryotic initiation of translation factor 3) domains, whereas their more divergent N-terminal parts extend radially outwards \[[@B17],[@B18],[@B30]\]. Architecturally, lid subunits are arranged in two lobes: five interlocking subunits in module 1 (Rpn5, Rpn6, Rpn8, Rpn9 and Rpn11) and three subunits in module 2 (Rpn3, Rpn7 and Rpn12) are tethered via the non-essential Rpn15 (a.k.a Sem1) subunit \[[@B17],[@B31]--[@B41]\]. No enzymatic information has been documented for lid subunits other than Rpn11. Apparently unrelated to its MPN^+^ enzymatic domain, the C-terminus of Rpn11 also plays a role in the stability of proteasomes and in mitochondrial integrity \[[@B42],[@B43]\]. The importance of the C-terminal segment of Rpn11 and how it participates in proteasome assembly and stability is the focus of the current study.

Construction of a large multi-subunit machine such as the proteasome is expected to require high precision \[[@B44]\]. 20S CP biogenesis is an ordered stepwise process requiring five dedicated chaperones that have been described in detail \[[@B45],[@B46]\]. At least four additional chaperones assist formation of the base as an independent sub-complex of the 19S RP \[[@B47]--[@B49]\]. Preassembled base may recruit lid subunits to generate a 19S RP precursor, which has been proposed to complex with 20S CP to form 26S proteasome holoenzyme \[[@B50]\]. Other observations, however, have noted that 20S CP may serve as a platform for layered assembly of 19S RP subunits \[[@B34],[@B51]\]. Regardless of assembly pathway, 19S RP can detach from proteasome holoenzymes and re-attach un-aided by chaperones \[[@B48],[@B52]--[@B55]\]. The lid too can detach and re-attach to base, the equilibrium of which is affected by various subunits such as Rpn10 or Sem1 \[[@B16],[@B39],[@B56]--[@B59]\].

Within the lid, module 2 subunits aided by Sem1 were proposed to assemble on to pre-assembled module 1 \[[@B38]\]. The final step was incorporation of Rpn12 marking the seal of proper lid \[[@B39],[@B60]\]. Thus far, module 1 is the only proteasome sub-complex for which no assembly chaperone has been reported \[[@B39],[@B61]\]. How does module 1 nucleate into a distinct sub-complex and what governs the association with the base on one side or module 2 on the other, were objectives of the present study. We show that both the MPN domain subunits, Rpn8 and Rpn11, play critical roles initiating lid assembly, without which lidless proteasomes were generated. More specifically, the C-terminal helix of Rpn11 linked module 2 to module 1 at the proteasome. Even in absence of this segment, module 1 retained its inherent DUB activity and was competent to bind base-CP both *in vitro* and *in vivo*. Loss of its C-terminus did substantially hamper ability of Rpn11 (incorporated on to module 1) and to recruit module 2. Proteasome specie consisting of module 1 base-CP has not been characterized before, yet we now find it abundant in rpn11--1 \[[@B42],[@B43],[@B55],[@B62]--[@B64]\].

EXPERIMENTAL
============

Yeast strains
-------------

[Table 1](#T1){ref-type="table"} contains a list of yeast strains used in the present study; the genetic background is based on BY4741:

###### Yeast strains used in the present study

The genetic background of the yeast strains used in the present study is based on BY4741

  Number   Gene               Characteristics                             Origin
  -------- ------------------ ------------------------------------------- -------------------
  MY58     WT                 *his3ko1; leu2ko0; met15ko0; ura3ko0*       Euroscarf
  MY1262   *tetO~2~--Rpn8*    *RPN8*::kanR*--*tetO~7~*--*TATA*--RPN8*     GE openbiosystems
  MY1263   *tetO~2~--Rpn11*   *RPN11*::kanR*--*tetO~7~*--*TATA*--RPN11*   GE openbiosystems
  MY1107   *rpn3--4*          *rpn3*::*rpn3--4--*TRP1                     \[[@B65]\]
  MY1070   *rpn5--1*          *rpn5*::*rpn5--1--*TRP1                     \[[@B34]\]
  MY1122   *rpn6--1*          *rpn6*::*rpn6--1*--URA3                     \[[@B66]\]
  MY1068   *rpn7--3*          *rpn7*::*rpn7--3*--URA3                     \[[@B67]\]
  MY1123   *rpn9ΔC*           *rpn9*::*rpn9ΔC*--LEU2                      \[[@B68]\]
  MY1119   *rpn12--1*         *rpn12*::*rpn12--1*--URA3                   \[[@B65]\]
  MY1268   *rpn11--m1*        *rpn11::rpn11--M1*                          \[[@B42]\]
  MY1284   *rpn8--1*          *rpn8::rpn8--1--LEU*                        Present study

Abbreviation: WT, wild-type.

[Table 2](#T2){ref-type="table"} contains a list of all plasmids used in the present study.

###### List of plasmids used in the present study

  Number   Gene                                 Vector    Origin
  -------- ------------------------------------ --------- ---------------
  M1364    Rpn5, Rpn6, Rpn8, Rpn9, his6-Rpn11   petDuet   \[[@B17]\]
  M1335    His~6~--Rpn11                        pQE30     present study
  M1388    Rpn8, His~6~--Rpn11                  petDuet   present study
  M1398    Rpn5, Rpn8, His~6~--Rpn11            petDuet   present study
  M1397    Rpn5, Rpn8, Rpn9, His~6~--Rpn11      petDuet   present study
  M1400    Rpn6, Rpn8, Rpn9, His~6~--Rpn11      petDuet   present study
  M1386    Rpn5, Rpn6, Rpn8, His~6~--Rpn11      petDuet   present study
  M1403    Rpn5, Rpn6, Rpn9, His~6~--Rpn11      petDuet   present study
  M1109    Rpn11 C-terminus                     pQE30     present study
  M899     Rpn11 C-terminus                     pRS425    \[[@B43]\]

The genetic background of the yeast strains used in the present study is based on BY4741

Native gel and Western blotting of whole cell extract
-----------------------------------------------------

Yeast whole cell extract (WCE) was prepared by glass beads vortexing in buffer A (25 mM Tris, pH 7.4, 5 mM MgCl~2~, 1 mM ATP 150 mM NaCl and 1 mM DTT) and cleared by centrifugation at 14000 ***g*** for 15 min. The soluble proteins were resolved using 4% native-PAGE, then visualized by LLVY-AMC peptidase activity assay during which the 0.1% SDS (w/v) was used in order to visualize the lower bands \[[@B16],[@B69],[@B70]\].

Antibodies
----------

The following antibodies were used to identify proteasome subunits: anti-Rpn1 and anti-Rpn2 \[[@B71]\]; anti-Rpt1 and anti-Rpt2 (present work); anti-Rpn11 \[[@B35]\], anti-Rpn12 (present work), anti-Rpn8 (present work) and anti-Rpn5 (gifts from Dan Finley).

Gene silencing
--------------

Strains with suppressible proteasome genes, *tetO~2~RPN8* (*tetO~2~*, tetracycline-regulatable promoter) and *tetO~2~RPN11*, were purchased from Openbiosystems. Gene silencing was induced by addition of 20 μg/ml tetracycline to growth media at *D* (600 nm)=0.5 and cells growth for indicated duration.

Glycerol gradient analysis
--------------------------

WCE containing 2--4 mg soluble protein was stacked on a 12 ml of 10%--40% glycerol gradient and ultracentrifuged at 100000 ***g*** for 20 h. One millilitre fractions were collected.

Proteasome and recombinant protein complex purification
-------------------------------------------------------

26S or lidless base-CP proteasomes were purified from WT or *rpn11--m1* yeast as described previously \[[@B16],[@B69],[@B70]\]. For expression of recombinant proteasome subunits in Rossetta cells (BL-21 with tRNA), genes were cloned into pETDuet (Novagen). In all subunit combinations, Rpn11 was tagged by His6 at N-terminus for affinity purification by Ni--NTA (HisTrapHQ 5 ml; GE open-biosystems; buffer containing 50 mM Tris, pH 7.4, 5% glycerol, NaCl 100 mM, imidazole 5--280 Mm) followed by size exclusive column (S400 120 ml; GE openbiosystems, 50 mM Tris, pH 7.4, 5% glycerol, NaCl 100 mM).

Proteasome resolution
---------------------

WCE from yeast cells was resolved by 4% non-denaturing-PAGE \[[@B55]\]. The peptidase activity based on LLVY--AMC tracing was the marker for cutting the gel slices. The native gel slices were modified with 100 mM iodoacetamide in 10 mM ammonium bicarbonate (at room temperature for 30 min) and trypsinized in 10 mM ammonium bicarbonate containing trypsin \[modified trypsin (Promega)\] at a 1:50 enzyme-to-substrate ratio, overnight at 37°C.

MS analysis
-----------

The resulting tryptic peptides were resolved by reverse-phase chromatography on 0.075×200 mm fused silica capillaries (J&W) packed with Reprosil reversed phase material (Dr Maisch GmbH, Germany). The peptides were eluted with linear 65 min gradients of 5%--45% and 15 min at 95% acetonitrile with 0.1% formic acid in water at flow rates of 0.25 μl/min. MS was performed by an ion-trap mass spectrometer (Orbitrap, Thermo) in a positive mode using repetitively full MS scan followed by collision induces dissociation (CID) of the seven most dominant ions selected from the first MS scan.

Database search
---------------

The MS data were analysed using the Trans Proteomic Pipeline (TPP) Version 4.3 \[[@B72]\]. TPP-processed centroid fragment peak lists in mzXML format were searched against *Saccharomyces cerevisiae* translations of all systematically named ORFs (open reading frames; <http://www.yeastgenome.org/>). The proteins were supplemented with their corresponding decoy sequences (as described in <http://www.matrixscience.com/help/decoy_help.html>). The database searches were performed using X! Tandem with *k*-score plugin through the TPP. Search parameters include: trypsin cleavage specificity with two missed cleavage, cysteine carbamidomethyl as fixed modification, methionine oxidation and protein N-terminal acetylation as variable modifications, peptide tolerance and MS/MS \[[@B35]\].

Preparation of Ub dimers
------------------------

Fully natural Ub dimers linked via Lys^6^, Lys^11^, Lys^27^, Lys^29^ and Lys^33^ were synthesized from recombinant Ub monomers using a non-enzymatic chain assembly method according to published protocol \[[@B73]\]. Monomeric Ub mutants, E2 conjugating enzymes and human E1 were purified from recombinant sources as described \[[@B74],[@B75]\]. Enzymatically synthesized Lys^11^-, Lys^48^- and Lys^63^-linked Ub dimers were assembled by combining a proximally blocked Ub mutant (UbD77 or 6His-Ub) in combination with a distally blocked lysine to arginine Ub variant as published \[[@B74],[@B76]\]. Lys^11^-linked dimers were obtained from a reaction containing 10 mg of each 6His-Ub and UbK11R/K63R, 500 nM UBE1, 30 μM Ube2s, 5 mM TCEP and 15 mM ATP in a volume of 2 ml with a 50 mM Tris, pH 8.0, buffer incubated at 30°C for 20 h. Lys^48^-linked dimers were obtained in a similar reaction with E2--25K as the sole E2 and UbD77 and UbK48R/K63R monomers. In a similar fashion, reactions to generate Lys^63^-linked dimers contained Ubc13 (ubiquitin-conjugating enzyme 13)--Uev1a (Ubc variant 1a) and UbD77 and UbK48R/K63R monomers. Following the completion of each reaction, 10 ml of cation buffer A (50 mM ammonium acetate, pH 4.5) was added, the solution was centrifuged at 14000 ***g*** for 10 min to remove precipitated E1 and E2 enzymes and the supernatant was injected on to a 5 ml cation-exchange (SP GE Life Sciences) column at 0.2 ml/min. The polyUb species were eluted with cation buffer B (50 mM ammonium acetate, 1 M NaCl, pH 4.5), exchanged into PBS buffer, pH 7.4, and concentrated to a final volume of 1 ml. Monomeric and dimeric Ub species were separated on a Superdex 75 size exclusion column (GE Life Sciences) in PBS buffer, pH 7.4, with a flow rate of 0.35 ml/min. Fractions containing pure dimers were detected using SDS/PAGE.

RESULTS
=======

Suppression of RPN8 or RPN11 disrupts lid assembly
--------------------------------------------------

Proteasome lid subunits are essential proteins for budding yeast viability; knocking-down any lid subunit (other than Rpn15/Sem1) in this organism results in lethality \[[@B5]\]. We employed inducible gene silencing to study proteasome integrity upon conditional loss of individual lid MPN subunits. Expression of *RPN8* and *RPN11* was placed under control of the repressible *tetO~2~* promoter, in order to repress their transcription upon addition of tetracycline directly to media \[[@B77]\]. Six to eight hours after tetracycline treatment, the levels of Rpn8 or Rpn11 in *tetO~2~RPN8* or *tetO~2~RPN11* strains respectively, decreased well below stoichiometry relative to other proteasome subunits ([Figure 1](#F1){ref-type="fig"}A). Exposure to tetracycline had no effect on the expression of *RPN12*, a result that served to evaluate expression levels of non-engineered proteasome subunits ([Figure 1](#F1){ref-type="fig"}A). Depletion of Rpn8 or Rpn11 in cells reduced levels of doubly- and singly-capped 26S holoenzymes (RP~2~CP, RP~1~CP). Concomitant appearance of faster migrating species was apparent ([Figure 1](#F1){ref-type="fig"}A). Stalled proteasome assembly was indicated by Rpn12 failing to incorporate into newly synthesized proteasomes, limited in either Rpn8 or Rpn11 ([Figure 1](#F1){ref-type="fig"}B). Migration of these proteasomes and composition determined by MS/MS ([Table 3](#T3){ref-type="table"}) resembled that of 'lidless' proteasomes previously identified upon deletion of *RPN10* \[[@B16]\]. Repression of *RPN8* or *RPN11* expression for longer periods (\~24 h) resulted in depletion of their gene products to below detection levels, growth arrest and eventual abrogation of proteasome complexes (Supplementary Figures S1 and S2). Interestingly, residual 20S CP remained in these arrested cells (Supplementary Figures S1 and S2). Persistent 20S CP in cells under a variety of stress conditions has been reported \[[@B53],[@B55]\].

![Silencing *RPN8* or *RPN11* suppresses lid biogenesis\
(**A**) *RPN8* and *RPN11* under control of the tetO~2~ were silenced by addition of 20 μg/ml tetracycline to growth media. At indicated time points, WCE was resolved by 4% non-denaturing (native)-PAGE (top) and 12% SDS/PAGE (bottom). Proteasome activity was traced by in-gel peptidase activity. Effect of tetracycline gene repression on cellular levels of proteasome lid subunits was monitored by immunoblotting specific antibodies as indicated. Majority of proteasomes in untreated cells migrated as doubly and singly capped 26S proteasomes (RP~2~CP, RP~1~CP respectively) and free 20S CP. After 6-h-treatment, faster migration species becomes apparent (top panel), concomitant with ablation of the target gene product in WCE (Rpn8 or Rpn11 accordingly; bottom panels). Composition of this new species was confirmed as base-CP lacking all lid subunits ([Table 3](#T3){ref-type="table"}). (**B**) Rpn12 ejected from *tetO~2~RPN8* and *tetO~2~RPN11* proteasomes. Eight hours after tetracycline treatment, WCE was resolved by native-PAGE and immunoblotted for presence of Rpn12 in proteolytically-active species. (**C**) Six hours following tetracycline treatment, heterogeneous proteasome species were resolved by fractionating native WCE (as in panel **A**) through a 10%--40% glycerol gradient. Each fraction was assayed for proteasome subunits (top panels) or proteolytic activity (bottom).](bsr2014-0173i001){#F1}

###### Subunits composition of Proteasome complexes from WT vs lid mutants. Proteasome complexes from WT or various mutants were traced in gels by peptidase activity and subunit composition determined by trypsinization and MS/MS analysis. The number of unique peptides of each identified proteasome subunit is listed. Complexes are marked in [Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}

  Strain:   WT   tetO~2~--RPN8   tetO~2~--RPN11   rpn11--m1   rpn8--1   rpn8--1                  
  --------- ---- --------------- ---------------- ----------- --------- --------- ---- ---- ---- ----
  Rpt1      9    13              9                17          8         12        21   7    20   22
  Rpt2      4    6               4                12          3         6         9    5    10   17
  Rpt3      4    3               2                10          8         14        12   6    13   17
  Rpt4      3    7               3                10          8         11        16   4    17   18
  Rpt5      5    8               2                20          6         11        17   3    18   23
  Rpt6      4    6               3                15          4         9         13   7    17   24
  Rpn1      11   11              7                19          14        22        28   4    31   27
  Rpn2      25   15              9                18          16        25        29   9    36   49
  Rpn13     2    2               1                --          1         3         5    --   2    3
  Ubp6      2    3               1                --          6         9         4    1    11   19
  Rpn10     2    --              --               --          2         --        17   --   --   1
  Rpn3      12   --              --               --          5         7         13   --   8    8
  Rpn5      4    --              --               2           4         6         11   --   8    8
  Rpn6      6    --              --               9           6         4         10   --   8    5
  Rpn7      3    --              --               --          4         4         9    --   4    4
  Rpn8      6    --              --               2           2         3         6    --   4    3
  Rpn9      12   --              --               7           9         6         11   --   13   4
  Rpn11     5    --              --               2           6         5         11   --   5    10
  Rpn12     2    --              --               --          4         2         9    --   1    1

Distribution of subunits between proteasome bound and unbound states was probed by centrifuging WCE through a glycerol density gradient. Most proteasome subunits migrated primarily in high *M*~r~ fractions consistent with 26S proteasome holoenzymes ([Figure 1](#F1){ref-type="fig"}C; left). Subunits of the proteasome base sub-complex, represented in this case by Rpn1, Rpn2, Rpt1 and Rpt2, were particularly synchronized with proteolytic activity (lower panels), indicating that most were in complex with 20S CP. Representative lid subunits, Rpn5, 8, 11 and 12, were also enriched in fractions containing proteasome holoenzymes, but trace amounts were found in lower *M*~r~ fractions, suggesting that a portion of lid subunits does not associate with 26S holoenzymes. Six hours after suppression of *RPN8* or *RPN11* expression, a proteasome specie containing all base subunits but lacking lid components was detectable ([Figure 1](#F1){ref-type="fig"}C). Migration patterns of the majority of lid subunits (including the residual Rpn8 and Rpn11 subunits that remained after suppression of their expression) were synchronized with migration of 26S proteasome holoenzymes. A notable exception was Rpn12, a significant portion of which was found detached from proteasomes in extracts from wild-type (WT) and even more so after suppression of *RPN8* or *RPN11* expression ([Figure 1](#F1){ref-type="fig"}C). That Rpn12 is one of the lid assembly intermediates \[[@B60]\] may explain why this subunit is able to remain stable and soluble in a proteasome-unbound state, in contrast with most other proteasome subunits that did not accumulate unassociated from proteasomes. Another subunit that was detected in fractions without peptidase activity characteristic of 20S CP was Rpn5 ([Figure 1](#F1){ref-type="fig"}C), in line with its dual association with COP9 signalosome (CSN) and proteasome complexes \[[@B35]\].

Partially assembled lid identified in proteasome species from rpn11--m1
-----------------------------------------------------------------------

Complete loss of lid from proteasome complexes in absence of Rpn8 or Rpn11 was unable to sustain growth over time (Supplementary Figures S1 and S2). In order to obtain information on their role in proteasome lid stability, we compared the outcomes of C-terminal truncations in each of the eight PCI and MPN domain lid subunits grown at their permissive temperature ([Figure 2](#F2){ref-type="fig"}A). Proteasomes isolated from *rpn11--m1* were unique in lacking any detectable incorporated Rpn12 ([Figure 2](#F2){ref-type="fig"}A). Proteasomes from this strain grow at the permissive temperature were proteolytically active but migrated faster than 26S holoenzymes suggesting a more substantial defect than merely loss of labile Rpn12 ([Figure 2](#F2){ref-type="fig"}B). Comparative MS/MS analysis of proteasome complexes from *rpn11--m1* and WT detect substantial loss of three lid subunits (Rpn3, 7 and 12) as well as the non-essential (peripheral) base subunits (Rpn10, Rpn13 and Ubp6) ([Table 3](#T3){ref-type="table"}). Base-CP, without any detectable lid subunits, typical of proteasomes purified in absence of Rpn10 \[[@B16]\], was also observed ([Figure 2](#F2){ref-type="fig"}B left and result not shown). *rpn8--1* partially emulated this feature; a proteasome specie lacking Rpn10 as well as complete lidless proteasomes alongside singly- and doubly-capped 26S proteasome holoenzymes ([Figure 2](#F2){ref-type="fig"}B; [Table 3](#T3){ref-type="table"}). Glycerol gradient fractionation confirmed base-CP proteasome species lacking lid subunits in this mutant ([Figure 2](#F2){ref-type="fig"}C).

![Participation of Rpn8 and Rpn11 C-termini in proteasome stability\
(**A**) WCE from mutants encoding proteasome lid subunits were resolved by non-denaturing-PAGE and immunoblotted with anti-Rpn12. (**B**) WCE from *rpn8--1* and *rpn11--m1* were also assayed for proteasome activity by '*in-gel peptidase activity*'. Subunits composition of indicated species is summarized in [Table 3](#T3){ref-type="table"}. (**C**) WCE from *rpn8--1* was fractionated through a 10%--40% glycerol gradient and each fraction evaluated for proteasome subunits (top panels) or proteolytic activity (bottom). (**D**) Proteasomes from WT and *rpn11--m1* were exposed to 300 mM NaCl and re-purified. Composition was estimated by immunoblotting for proteasome subunits representing each of the 19S-RP sub-complexes. (**E**) Migration of proteasomes from WT and *rpn11--m1* in native gel before and after exposure to 300 mM NaCl.](bsr2014-0173i002){#F2}

Absence of Rpn10 has been shown previously to render proteasome holoenzymes fragile and particularly sensitive to salt leading to rapid dissociation of entire lid after exposure to \~300 mM NaCl \[[@B16]\]. Proteasomes from *rpn11--m1* were exposed to low 300 mM NaCl in buffer and re-isolated. No lid subunits remained stably associated with base-CP complexes, in contrast with 26S proteasomes from WT that were resilient to this treatment ([Figure 2](#F2){ref-type="fig"}D). Following salt treatment, proteasomes from *rpn11--m1* migrated slightly faster by non-denaturing gels ([Figure 2](#F2){ref-type="fig"}E), further supporting change in subunit composition (loss of residual lid subunits). Likewise, MS/MS did not pick up peptides derived from lid subunits in these samples (3). Consequentially, we wish to comment that proteasome subunit composition should not be concluded solely from migration patterns in non-denaturing gels. Although the standard protocols for native gels are powerful in distinguishing 20S CP from singly- and doubly-capped 26S holoenzymes, changes within 19S and lid seem much harder to resolve, even when involving multiple subunits.

C-terminal helix of Rpn11 recruits labile proteasome lid subunits
-----------------------------------------------------------------

Three lid subunits, Rpn3, Rpn7 and Rpn12, were not detected in proteasomes isolated from a mutant lacking the last 31 amino acids of Rpn11 ([Figure 2](#F2){ref-type="fig"}; [Table 3](#T3){ref-type="table"}). Nevertheless, absence of this Rpn11 tail did not abrogate the ability of module 1 subunits in the lid to bind base-CP and give rise to a previously undocumented incomplete proteasome complex. Co-expression of both Rpn11 fragments restored typical proteasome configuration even though the two domains of Rpn11 were not physically bound to each other ([Figure 3](#F3){ref-type="fig"}A) \[[@B78],[@B79]\]. Moreover, addition of a recombinant polypeptide identical in sequence to the C-terminal segment of Rpn11 *rpn11--m1* extracts was sufficient to generate 26S proteasome holoenzymes, apparently by recruiting free module subunits ([Figure 3](#F3){ref-type="fig"}B). In either case, complete 26S holoenzymes composition was confirmed by MS/MS ([Table 3](#T3){ref-type="table"}). These experiments demonstrate distinct structural roles for the MPN and C-terminal domains of Rpn11. Whereas the MPN domain appears sufficient to recruit co-ordinate Rpn11 into module 1 and incorporation into proteasomes, the C-terminal segment emerges as critical for retaining module 2 subunits in 19S RP of the 26S holoenzymes. Notably, both fragments of Rpn11 were present in tandem in reconstituted holoenzymes, even if not physically attached ([Figure 3](#F3){ref-type="fig"}C). The labile subunit Rpn12 was re-incorporated into proteasomes merely by presence of the C-terminal fragment of Rpn11 ([Figure 3](#F3){ref-type="fig"}C), further supporting a role for Rpn11 in linking modules 1 and 2.

![The C-terminus of Rpn11 is capable of recruiting missing module 2 subunits\
(**A**) The C-terminus fragment of Rpn11 was expressed as a separate gene product in *rpn11--m1* background; proteasome species were compared with WT by in-gel peptidase activity (right) followed by immunoblotting by anti-Rpn12 (left). (**B**) WCE of *rpn11--m1* (or WT) was incubated for 30 min with or without a recombinant polypeptide corresponding to the C-terminus of Rpn11; proteasomes were then visualized by in-gel peptidase activity. (**C**) WCE of *WT*, *rpn11--m1* and *rpn11--m1* expressing the C-terminal fragment were resolved by glycerol gradient; all fractions were immunoblotted by anti-Rpn11 to monitor distribution of Rpn11 or its fragments.](bsr2014-0173i003){#F3}

The minimal lid composition competent to bind base-CP
-----------------------------------------------------

By characterization of proteasome species in mutants, we have learned that it is possible for proteasome complexes to contain only a portion of lid subunits. Module1--base-CP proteasomes could reflect transiently-associated module 2 that easily detaches during isolation procedures or an assembly intermediate that has difficulty to recruit module 2 due to the mutation in Rpn11. In order to demonstrate whether module 1 can self-assemble and bind directly to base-CP, we generated a recombinant module 1 complex. Tagged Rpn11 was co-expressed in various combinations with other module 1 subunits in *Escherichia coli* and isolated by Ni--NTA affinity purification followed by size exclusion chromatography. Without Rpn8, no complexes of Rpn11 with other lid subunits were detected ([Figure 4](#F4){ref-type="fig"}A). Heterodimerization of Rpn8 and Rpn11 yielded stable dimers independent of any other factors ([Figures 4](#F4){ref-type="fig"}A and [4](#F4){ref-type="fig"}B). Indeed, dimerization is probably mediated by their MPN domains \[[@B13],[@B61]\]. In absence of Rpn5, this Rpn8--Rpn11 dimer was unable to recruit other lid subunits. Next, a stable Rpn5--Rpn8--Rpn11 trimer was independent of Rpn6 or Rpn9 ([Figure 4](#F4){ref-type="fig"}A). A sequential order of subunit addition during module 1 assembly was confirmed by a stepwise expression of subunits ([Figure 4](#F4){ref-type="fig"}B). Co-expression of all five subunits self-assembled into a stable module 1 ([Figures 4](#F4){ref-type="fig"}A and [4](#F4){ref-type="fig"}B). The resulting module 1 was validated for its inherent deubiquitination activity. Homogenously-linked dimeric Ub linked through each of the seven possible lysines, was incubated with module 1 and products separated by SDS/PAGE. Monoubiquitin was generated primarily from Lys^11^--Ub2 and for Lys^63^--Ub2, reported to be the preferred linkages of Rpn11 \[[@B13]\], and to a lesser extent from Lys^48^, Lys^6^ and even Lys^33^ Ub2 ([Figure 4](#F4){ref-type="fig"}C). A reaction time course demonstrated deubiquitination activity by module 1 for Lys^11^, Lys^63^ and Lys^48^ linked substrates ([Figure 4](#F4){ref-type="fig"}D).

![Reconstitution of proteasome lid mini-complexes revolving around Rpn11\
(**A**) Recombinant His~6~--Rpn11 was co-expressed in *E*. *coli* alongside all lid module 1 subunits (Rpn5, Rpn6, Rpn8 or Rpn9 respectively) or in various combinations lacking one of the subunits from lid module 1 (Rpn5, Rpn6, Rpn8 and Rpn9). His~6~-tagged Rpn11 and associated proteins were tandem affinity purified and evaluated for composition (identify of all protein bands were confirmed by MS/MS). (**B**) Recombinant His~6~--Rpn11 was expressed in *E*. *coli*, in various combinations with other subunits from lid module 1 (Rpn5, Rpn6, Rpn8 and Rpn9). His~6~-tagged Rpn11 and associated proteins were tandem affinity purified and evaluated for composition (identify of all protein bands were confirmed by MS/MS). (**C**) Recombinant module 1 is an active DUBs. Fully natural Ub dimers linked via Lys^6^, Lys^11^, Lys^27^, Lys^29^, Lys^33^, Lys^48^ or Lys^63^ were synthesized from recombinant Ub monomers. Ten micromolar of each Ub dimer was incubated with 1 μM of purified recombinant module 1. (**D**) Ten micromolar of enzymatically synthesized Lys^11^--Ub~2~, Lys^48^--Ub~2~ or Lys^63^--Ub~2~ were incubated with 1 μM of the indicated enzyme and visualized by Coomassie stained SDS/PAGE.](bsr2014-0173i004){#F4}

Stable mini-complexes of module 1 were tested whether they were able to integrate into proteasomes by association with pre-assembled base-CP, purified as published \[[@B16]\]. The only complex competent to attach to base-CP was module 1 that included Rpn6 ([Figure 5](#F5){ref-type="fig"}A). In this manner, it was possible to reconstitute *in vitro*, a module1--base-CP complex, identical in composition to incomplete proteasomes abundant in *rpn11--m1* ([Table 3](#T3){ref-type="table"}). Recent EM studies position Rpn11 at the centre of proteasome holoenzyme, situated directly above the hexameric ring of ATPases \[[@B18],[@B27]\]. To obtain biochemical insight as to which RPTs Rpn11 is in close contact with, we tested pairwise associations of Rpn11 with each ATPase. We found that Rpt1, Rpt3, Rpt4 and Rpt6 formed stable associations with Rpn11 ([Figure 5](#F5){ref-type="fig"}B). Even lacking its C-terminal residues, Rpn11 was incorporated into proteasomes ([Figure 3](#F3){ref-type="fig"}). Interestingly, this truncated reduced the ability to bind Rpt6 and Rpt3, yet retained stable association with Rpt1 and Rpt4 ([Figure 5](#F5){ref-type="fig"}B). We conclude that within the proteasome holoenzyme, the C-terminal region of Rpn11 interacts with distinct partners from those that associate with its MPN domain. These interactions orient module 2 within the 19S RP ([Figure 6](#F6){ref-type="fig"}).

![Base-CP can serve as a platform for stepwise lid formation\
(**A**) Stably purified lid intermediates from [Figure 4](#F4){ref-type="fig"}(**B**) were incubated with purified base-CP (equivalent to lidless proteasome) and resulting association monitored by proteolytic assay on native gel. (**B**) Specific interactions of Rpn11 with RPT ATPases depends on C-terminal fragment. Each RPT ATPase was purified and immobilized on CH-sepharose beads and incubated with either full-length Rpn11 or Rpn11ΔC. Beads with immobilized BSA were used as a negative control (mock). Bound proteins were separated on SDS/PAGE and immunoblotted with anti-Rpn11. (**C**) Assembly pathway of lid module 1. Relative orientation of subunits is based on PDB 4CR2. (**D**) Module 1 can serve as a *de facto* lid core. A summary of proteasome species identified in the present study, from left to right: 1. base-CP, 2. module1--base-CP, 3. incomplete 26S identified in *rpn11--m1* containing a lid core, 4. proteasomes from *rpn11--m1* upon addback of Rpn11 C-terminal fragment and 5. 26S proteasome holoenzymes. Relative orientation of lid subunits running along the side of the base (illustrated as a pink mound) is based on PDB 4CR2. Schematic depiction of main sub-complexes and key lid subunits as follows: brown cylinder, 20S CP; pink mound, base; blue, lid core (module 1) subunits; red, labile (module 2) lid subunits; violet, Rpn10 bridging lid and base.](bsr2014-0173i005){#F5}

![Prying open the two domains of Rpn11 in the 26S proteasome\
Position of Rpn11 (green) in 26S holoenzymes from EM model (PDB-4CR2) supports distinct interactions of MPN domain and C-terminal region. Lid PCI domains and Ub-processing factors in the base (Rpn1, Rpn2, Rpn10 and Rpn13) were rendered invisible in order to highlight the relative position of Rpn11 (green) to the ring of RPT ATPases. Rpt1 (red), Rpt2 (dark red), Rpt3 (light blue), Rpt4 (dark orange), Rpt5 (orange) and Rpt6 (blue). The hexameric RPT ring locks on to the 20S CP made up of the distal α-heptamer (dark grey) and the proteolytic β-heptamer (light grey). Note the pairing of RPTs via N-terminal coiled-coils: Rpt1--Rpt2, Rpt4--Rpt5 and Rpt3--Rpt6. Rpn11 catalytic MPN domain is situated directly above the centre of this hexameric RPT ring with its C-terminal segment pried away wrapping around the Rpt3--Rpt6 coiled-coil. The unique orientation of Rpn11 enables it to bridge between lid module 1 and module 2: remainder of module 1 subunits (Rpn5, Rpn6, Rpn8 and Rpn9) co-ordinate around the MPN domain of Rpn11, whereas the α-helix at its C-terminus participates in a helix bundle with C-termini of its paralogue Rpn8 and module 2 subunits (Rpn3, Rpn7 and Rpn12).](bsr2014-0173i006){#F6}

DISCUSSION
==========

Proteasomes are strictly required for viability of all eukaryotic cells. Nevertheless, fragile complexes or proteasomes lacking certain subunits have been documented in mutants or under stress conditions. For this reason, mutants have been instrumental in dissecting assembly pathways, mapping nearest neighbour interactions and determining complex stability \[[@B3],[@B34],[@B42],[@B43],[@B49],[@B51],[@B59],[@B66],[@B67],[@B78],[@B80]--[@B84]\]. Similarly, by knocking down either of the MPN-subunits, Rpn11 or Rpn8, we have demonstrated that base was still assembled in cells associated to 20S CP. Heterodimerization of Rpn8--Rpn11 appeared to be a key step for initiation of lid assembly, followed by addition of Rpn5, with Rpn9 and Rpn6 coming in last to form module 1 ([Figure 5](#F5){ref-type="fig"}C). The resulting five-subunit complex corresponds to lid assembly intermediate module 1, which we now demonstrate is competent to bind base-CP ([Figure 5](#F5){ref-type="fig"}D). Once incorporated into proteasomes, module 1 serves in effect as the 'lid core' sustaining a proteasome species prevalent in certain mutants and easily reconstituted from isolated components *in vitro* ([Figure 5](#F5){ref-type="fig"}D). The current study provides evidence that module 2 subunits are present in cell extract and are able to re-attach to proteasome complexes. However, we have no evidence, thus far, whether module 2 exists as an independent stable complex when detached from module 1. The Rpn11 C-terminus was demonstrated as a critical factor in stabilizing incorporation of module 2 subunits on to 26S holoenzymes. The positon of Rpn11 obtained from high-resolution EM models highlights the bipartite nature of its structure ([Figure 6](#F6){ref-type="fig"}), its centrally located MPN domain co-ordinates module 1, whereas the C-terminus wraps around Rpt3--Rpt6 coiled-coil extension positioned to anchor module 2 in the 19S RP. Subunit arrangement within the lid and its overall architecture is remarkably similar to that of the CSN complex \[[@B36]\], yet in contrast to Rpn11, Csn5, the active metallo-protease and direct paralogue of Rpn11, is labile and can be the last to incorporate or first to detach \[[@B85]\]. Differences in assembly and stability of these two complexes may control of their respective enzymatic activities; whereas CSN is maintained as an inactive protease until bound to its Cullin substrate \[[@B85]--[@B87]\], lid and module 1 are active relative to free Rpn11 ([Figure 4](#F4){ref-type="fig"}) \[[@B10],[@B13]\].

Isolated Rpn11 is latent, yet can be partially activated either when incorporated into 26S proteasome holoenzymes or by truncation of its C-terminal sequence \[[@B13]\]. The current study provides a possible explanation; repression of Rpn11 catalytic activity by its C-terminal tail may be alleviated by a conformational change that distances the C-terminus from the globular MPN domain as occurs in the proteasome ([Figure 6](#F6){ref-type="fig"}). Seeing as Rpn11 in module 1 displays elevated rates of DUB activity compared to Rpn11 or Rpn11--Rpn8 heterodimer \[[@B13]\], we propose that conformational changes upon binding of Rpn5 or other neighbours in module 1 ([Figures 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}) may be sufficient to partially alleviate repression by the C-terminus of Rpn11. Such an allosteric effect may be a boon to enzymatic studies of Rpn11 properties and facilitate screening of inhibitors. Although the C-terminus of Rpn5 has not been proposed to participate in the tight helix bundle composed of the extreme C-termini of most lid subunits \[[@B61]\], our biochemical data establish a stable association between Rpn5 the Rpn8--Rpn11 heterodimer. This association is likely to be through its C-terminus \[[@B34],[@B35]\]. Furthermore, this trimeric complex is a prerequisite for formation of module 1.

Multi-subunit complexes, such as the proteasome, may enlist multiple assembly pathways to guarantee robust production. In the present study, module 1 was assembled independently and was found to be competent to bind base-CP, however in the crowded milieu of the cytosol, other assembly pathways may exist in parallel. For instance, complete assembly of lid \[[@B34]\], stepwise assembly of lid on base initiated by one of the subunits with highest affinity for base (such as Rpn6 \[[@B88]\] or Rpn11 \[[@B51]\]) or complete preassembly of the 19S RP before attachment to 20S \[[@B17],[@B60]\] are alternative pathways that may each lead to 26S proteasome assembly. Once assembled, 19S RP and 20S CP may dissociate in cells or in biochemical preparations \[[@B48],[@B52]--[@B54]\], although disassembly and assembly need not to follow an identical itinerary. The equilibrium of 19S RP with 20S CP can be perturbed by external stress conditions, senescence, neurodegeneration, aging or influenced through mutation of subunits \[[@B16],[@B34],[@B51],[@B55],[@B66],[@B67],[@B89]--[@B92]\].

Characterization of the module1--base-CP intermediate provides new information for the importance of Rpn6 in determining proteasome stability \[[@B93],[@B94]\]. Rpn6 is an elongated super-helical subunit that physically links all three sub-complexes: lid, base and CP ([Figure 5](#F5){ref-type="fig"}). Beyond participating in the helix bundle tying lid subunits together, Rpn6 also simultaneously interacts with Rpt6 and α2 \[[@B66],[@B88]\]. This property explains the decisive role that Rpn6 has in partitioning between 19S assembly pathways, depending on availability of partners and relative strength of interactions. Similarly, Rpn11 also bridges several RPTs, module 1 and module 2 subunits. Module 1 apparently revolves around the MPN domain heterodimer of Rpn8 and Rpn11. The current study also illuminates a critical role for the C-terminal residues of Rpn11 in docking of module 2 components ([Figures 5](#F5){ref-type="fig"}D and [6](#F6){ref-type="fig"}). It is notable that all module 2 subunits participate along with Rpn11 in the helix bundle through their respective C-termini. This may explain why module 2 subunits were not found in proteasomes studied from the *rpn11--m1* mutant ([Figures 2](#F2){ref-type="fig"}--[3](#F3){ref-type="fig"}). Identifying a new proteasome species in an *rpn11* mutant is an insightful development towards charting alternative routes for biogenesis of 26S proteasome holoenzymes and for defining functional units within this intricate machine.
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